Technology | May 11, 2009

Preventing SCA Using Early Detection by Microvolt T-Wave Alternans


May 11, 2009 - With 12 million Americans at risk for sudden cardiac arrest (SCA), Cambridge Heart’s Microvolt T-Wave Alternans (MTWA) diagnostic test reportedly offers a cost-effective treadmill test to identify those at high or low risk.

Clinical evidence recently published in the Heart Rhythm Journal (1) indicates a need for more widespread use of MTWA, which is said to be 1,000 times more sensitive than an ECG in detecting tiny heartbeat irregularities closely associated with SCA risk. MTWA is also a consistently accurate predictor of SCA, according to a 6,000 patient meta-analysis and four supporting studies recently published by Heart Rhythm Journal (2).

Cambridge Heart said with recently published conclusive evidence putting to rest any past controversies, and with the Obama administration’s focus on prevention and cost-cutting, MTWA is likely to become more widely adopted.

MTWA is among the tests used routinely by the nations’s top heart programs to determine how likely an individual patient is to have a sudden cardiac arrest and whether the patient needs, or does not need, treatment to prevent SCA, the company said. Despite American College of Cardiology, American Heart Association and European Society of Cardiology guidelines to use the test to improve risk stratification, the MTWA test is underutilized given its proven clinical benefit and demonstrated cost-effectiveness, the company said. MTWA test results also help physicians convince often-reluctant high-risk patients that they really do require medical treatment or an ICD, Cambridge Heart said.

Cambridge Heart’s MTWA is the only T-wave alternans test reimbursed by Medicare.

Cambridge Heart will showcase its MTWA at Heart Rhythm 2009 this week at:

• Hands-on-session: live MTWA testing, 11 a.m. to 3:30 p.m. Wednesday, May 13, Learning Lab, Room 210

• SCD Prevention: Risk Stratification Beyond EF
Expert panel: MTWA experts Otto Costantini, M.D. and David Rosenbaum, M.D., 4:30 to 5:30 p.m. Friday, May 15, Room 160

1. www.heartrhythmjournal.com/issues/contents?issue_key=S1547-5271(09)X0006-8

2. www.heartrhythmjournal.com/article/PIIS1547527108009788/fulltext

For more information: www.cambridgeheart.com

 


Related Content

News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Subscribe Now